Printer Friendly

RML TO PROPOSE CHANGE OF NAME AT AUGUST 24 ANNUAL MEETING

RML TO PROPOSE CHANGE OF NAME AT AUGUST 24 ANNUAL MEETING
 TORONTO, July 7 /PRNewswire/ -- RML Medical Laboratories Inc., a leading biotechnology company developing proprietary biologic response modifier technology and products for the treatment of cancer and other diseases, today announced that it plans to ask shareholders to approve a change in the company's name to IMUTEC Corporation at the company's annual and special meeting on August 24, 1992.
 The meeting will be held at 11:00 a.m. at the Corporate Seminar Centre, Conference Room Q1, located at 121 King Street West (at York), 24th floor, Toronto, Ontario M5H 3T9.
 "We believe IMUTEC better captures the nature of our work on human immune system response," said Richard A. Potts, RML president. "In addition, the new name is more memorable and will contribute to greater name recognition as we continue to move toward commercialization."
 RML's VIRULIZIN(TM) is currently undergoing Phase II clinical trials at prominent hospitals in Canada and Mexico on five types of cancer: pancreas, melanoma, kidney, stomach, and recurrent colon and rectum.
 On July 14, 1992, RML will move to a new and substantially larger research, manufacturing and administration facility located at 1285 Morningside Avenue, Scarborough, Ontario M1B 3W2.
 -0- 07/07/92
 CONTACT: David W. Cooke, director of corporate development of RML Medical Laboratories, 416-449-4060; New telephone changes effective July 20, 1992, 416-724-1100; fax, 416-724-1167 CO: RML MEDICAL LABORATORIES INC. IN: MTC ST: -- NY052 -- X779 07/07/92
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 7, 1992
Words:242
Previous Article:NATIONSBANK SIGNS WON'T REPLACE NCNB AND C&S SIGNS IN FLORIDA UNTIL FALL
Next Article:IMAGE ENTERTAINMENT AND FOXVIDEO SIGN NEW LONG-TERM EXCLUSIVE DISTRIBUTION AGREEMENT
Topics:


Related Articles
RML EXPANDS CANCER TREATMENT CLINICAL TRIALS
REITER APPOINTED RML DIRECTOR
RML FILES FINAL PROSPECTUS
RML ANNOUNCES CHANGE OF NAME TO IMUTEC CORPORATION
RML Trading Selects PC Quote Real-Time Data to Use With Microsoft's 'Netshow' Technology
HCC to Acquire Specialty Lloyds Insurance Broker.
HCC Acquires Specialty Lloyds Reinsurance Broker.
Nortel Networks Introduces Free On-line Configuration and Management Tools for Improving Efficiency and Easing Deployment of Large Router Networks.
Nyer Medical Group, Inc. and National Distribution & Contracting, Inc., Announce Purchase Agreement of Nyer Nutritional Systems, Inc. Contingent Upon...
Russell Corporation Board of Directors Approves Reincorporation Proposal, Shareholders to Vote at Annual Meeting.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters